Cargando…

Acute toxicities of patients with locally advanced rectal cancer treated with intensified chemoradiotherapy within the CAO/ARO/AIO-12 trial: comparing conventional versus VMAT planning at a single center

In locally advanced rectal cancer (LARC) neoadjuvant chemoradiotherapy is regarded as standard treatment. We assessed acute toxicities in patients receiving conventional 3D-conformal radiotherapy (3D-RT) and correlated them with dosimetric parameters after re-planning with volumetric modulated arc t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zimmermann, Marcus, Richter, Anne, Weick, Stefan, Exner, Florian, Mantel, Frederick, Diefenhardt, Markus, Fokas, Emmanouil, Kosmala, Rebekka, Flentje, Michael, Polat, Bülent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731986/ https://www.ncbi.nlm.nih.gov/pubmed/36481692 http://dx.doi.org/10.1038/s41598-022-25647-8

Ejemplares similares

Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial
por: Diefenhardt, Markus, et al.
Publicado: (2022)

Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial: Early Surrogate Endpoints Revisited
por: Diefenhardt, Markus, et al.
Publicado: (2022)

ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group
por: Fleischmann, Maximilian, et al.
Publicado: (2022)

Impact of beam configuration on VMAT plan quality for Pinnacle(3)Auto-Planning for head and neck cases
por: Richter, Anne, et al.
Publicado: (2019)

Chemoradiotherapy by intensity-modulated radiation therapy with simultaneous integrated boost in locally advanced or oligometastatic non-small-cell lung cancer—a two center experience
por: Mantel, Frederick, et al.
Publicado: (2021)

Comparison of treatment plans for hypofractionated high‐dose prostate cancer radiotherapy using the Varian Halcyon and the Elekta Synergy platforms
por: Tamihardja, Jörg, et al.
Publicado: (2021)

Complete response after chemoradiotherapy for rectal cancer: what is the reasonable approach?
por: Rödel, Claus, et al.
Publicado: (2017)

Initial results for patient setup verification using transperineal ultrasound and cone beam CT in external beam radiation therapy of prostate cancer
por: Richter, Anne, et al.
Publicado: (2016)

Evaluation of a software module for adaptive treatment planning and re-irradiation
por: Richter, Anne, et al.
Publicado: (2017)

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
por: Lewitzki, Victor, et al.
Publicado: (2019)

Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma
por: Polat, Bülent, et al.
Publicado: (2022)

Overall Survival After Treatment Failure Among Patients With Rectal Cancer
por: Diefenhardt, Markus, et al.
Publicado: (2023)

Eine Monotherapie mit Immuncheckpointblockade führt bei Patienten mit Rektumkarzinom und Mikrosatelliteninstabilität zur klinischen Komplettremission
por: Diefenhardt, Markus, et al.
Publicado: (2022)

Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the Interdisciplinary Working Group Gastrointestinal Tumours (AIO, ARO, and CAO)
por: Brunner, Thomas B, et al.
Publicado: (2007)

Reply: Adjuvant chemoradiotherapy is no alternative to intensified neoadjuvant chemoradiotherapy for local and systemic control in patients with locally advanced rectal cancer
por: Klautke, G, et al.
Publicado: (2006)

Comparison of sliding window and field-in-field techniques for tangential whole breast irradiation using the Halcyon and Synergy Agility systems
por: Richter, Anne, et al.
Publicado: (2021)

Non-rigid image registration of 4D-MRI data for improved delineation of moving tumors
por: Weick, Stefan, et al.
Publicado: (2020)

Treatment plan comparison for irradiation of multiple brain metastases with hippocampal avoidance whole brain radiotherapy and simultaneous integrated boost using the Varian Halcyon and the Elekta Synergy platforms
por: Kraft, Johannes, et al.
Publicado: (2022)

Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer
por: Klautke, G, et al.
Publicado: (2005)

Image-guided high-dose-rate brachytherapy for rectal cancer: technical note and first clinical experience on an organ-preserving approach
por: Fleischmann, Maximilian, et al.
Publicado: (2022)

Aios in coronatijd
por: Maria Greijn, Claudia, et al.
Publicado: (2020)

Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis
por: Tamihardja, Jörg, et al.
Publicado: (2021)

Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer
por: Tamihardja, Jörg, et al.
Publicado: (2022)

RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV
por: Lorenzen, Sylvie, et al.
Publicado: (2020)

VMAT planning study in rectal cancer patients
por: Shang, Jun, et al.
Publicado: (2014)

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
por: Tamihardja, Jörg, et al.
Publicado: (2020)

Impact of Radiotherapy on Malfunctions and Battery Life of Cardiac Implantable Electronic Devices in Cancer Patients
por: Lisowski, Dominik, et al.
Publicado: (2023)

Major QTLs, qARO1 and qARO9, Additively Regulate Adaxial Leaf Rolling in Rice
por: Jang, Su, et al.
Publicado: (2021)

The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI
por: Al-Batran, Salah-Eddin, et al.
Publicado: (2017)

AIOS proceedings: A response
por: Rajendran, Babu
Publicado: (2009)

19. AIO-Herbstkongress 2022
Publicado: (2023)

Toxicity, Disease Control, and Survival Outcomes of Intensified Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Single-Institution Study
por: Qiu, Xiangnan, et al.
Publicado: (2023)

Sarcopenia Is Associated With Hematologic Toxicity During Chemoradiotherapy in Patients With Anal Carcinoma
por: Martin, Daniel, et al.
Publicado: (2020)

Kynurenine aminotransferase activity of Aro8/Aro9 engage tryptophan degradation by producing kynurenic acid in Saccharomyces cerevisiae
por: Ohashi, Kazuto, et al.
Publicado: (2017)

Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer
por: Tamihardja, Jörg, et al.
Publicado: (2021)

Practicar y jugar con el aro
por: Seybold-Brunnhuber, Annemarie
Publicado: (1975)

Bericht vom ARO-Mentoring-Tag 2022
Publicado: (2023)

CAO
Publicado: (1986)

Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
por: Schiffmann, Leif, et al.
Publicado: (2013)

Molecular Mechanism of Sirtuin 1 Modulation by the AROS Protein
por: Weiss, Sandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4fs72s6kdaciboad8nbpn1v31n